Boosts vitality and accelerates recovery
It will undoubtedly cause some concerns about the ability of a leaner FDA, with a potentially lighter regulatory touch, to maintain the crucial balance between rigorous oversight and flexible, creative solutions, and to reassure both the public and politicians that drug innovation is being embraced and rewarded, without compromising standards of efficacy, safety, quality and scientific independence
A5 is similar to dipeptide WY, while B16 features a KFY structure, suggesting that C-terminal tyrosine residues play an important role in the tyrosinase inhibition
ELV001 targets pathways that may contribute to persistent synovial pathology, and we hope START-SYNERGY will provide key insights into improving outcomes." Professor Dominique Baeten, CMO of Elevara Medicines, added: "Synovial fibroblasts are increasingly recognized as contributors to RA persistence
& Ravizza, T